PHILADELPHIA--The NCCN (National Comprehensive Cancer Network) has
received a $1 million unrestricted grant from Genentech, Inc. The
grant, provided over a 2-year period, will be used to support the
development and expansion of the NCCN Oncology Outcomes Database with
emphasis on breast cancer and non-Hodgkins lymphoma.
The NCCN, established in 1995, is a coalition of 17 leading US cancer
centers. To date, the network has developed Oncology Practice
Guidelines, which are steadily becoming the standard for clinical and
coverage policy in cancer care. To date, NCCN guidelines are
available for 93% of all cancers.
The NCCN Oncology Outcomes Database was launched recently in an
effort to provide patients, physicians, and payers with a constant
flow of data and information to facilitate optimal decision-making in
the treatment of all cancers.
"This agreement with Genentech affirms the critical importance
of the NCCNs Oncology Outcomes Database, as well as NCCNs
commitment to the highest quality of cancer care through excellence
in research and the collection and analysis of outcomes data," said
NCCN chief executive officer William T. McGivney, PhD, commented,
"NCCN implementation of practice guidelines through performance
measurement establishes the model for continuous quality improvement
in cancer care."